Cowen & Co Upgrades Natus Medical (BABY) to Outperform
BABY Hot Sheet
Rating Summary:1 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
Cowen & Co upgrades Natus Medical (Nasdaq: BABY) from Neutral to Outperform.
To see more analyst ratings on BABY Click Here.
Natus Medical Incorporated develops, manufactures, and markets neurondiagnostic and newborn care products worldwide.
To see more analyst ratings on BABY Click Here.
Natus Medical Incorporated develops, manufactures, and markets neurondiagnostic and newborn care products worldwide.
You May Also Be Interested In
- UPDATE: Williams Financial Group Upgrades Semtech Corp. (SMTC) to Buy; Check Again...Quarter Was Fairly Strong
- UBS Maintains a 'Buy' on Teva Pharma (TEVA); CEO Highlights From Conference Call
- JPMorgan Upgrades Illinois Tool Works (ITW) to Overweight
Create E-mail Alert Related Categories
UpgradesRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
